Лечение и препараты

<![CDATA[FDA Approves Rusfertide in Polycythemia Vera]]>

New combination therapy shows promise in metastatic pancreatic cancer - Medical Xpress

New combination therapy shows promise in metastatic pancreatic cancer Medical Xpress

FDA approves new treatment for hard-to-treat pancreatic cancer

The U.S. Food and Drug Administration announced Wednesday the approval of a treatment for pancreatic cancer that could usher in a new era in managing one of the deadliest forms of the disease.

FDA Approves Drug for Advanced Pancreatic Cancer | Newswise - Newswise

FDA Approves Drug for Advanced Pancreatic Cancer | Newswise Newswise

Breakthrough pancreatic cancer drug approved by the FDA - PhillyVoice

Breakthrough pancreatic cancer drug approved by the FDA PhillyVoice

FDA approves pancreatic cancer drug that extends patients’ lives - The Washington Post

FDA approves pancreatic cancer drug that extends patients’ lives The Washington Post

В Аделаиде изучают точную лучевую терапию рака мозга - UA.NEWS

В Аделаиде изучают точную лучевую терапию рака мозга UA.NEWS

Inherited genetic variants help identify patients at higher risk of aggressive therapy-related blood cancers

Some patients develop aggressive blood cancers years after receiving chemotherapy or radiotherapy for a previous cancer. These conditions, known as therapy-related myeloid neoplasms (t-MN), are currently classified mainly according to a patient's treatment history, even though their clinical course can vary…

New drug poised to transform pancreatic cancer care after FDA approval - WXYZ Channel 7

New drug poised to transform pancreatic cancer care after FDA approval WXYZ Channel 7

FDA approves life-extending pancreatic cancer drug Rasonque - USA Today

FDA approves life-extending pancreatic cancer drug Rasonque USA Today

FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival - The Conversation

FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival The Conversation

Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters

Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters

FDA approves breakthrough pancreatic cancer drug proven to extend survival - Washington Examiner

FDA approves breakthrough pancreatic cancer drug proven to extend survival Washington Examiner

Rasonque earns FDA approval for pancreatic cancer

The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib (Rasonque, Revolution Medicines), an RAS inhibitor, received approval for patients who previously received at least one prior line of systemic therapy and are not candidates for multiagent systemic…

FDA Approves Rasonque™ (daraxonrasib) - Pancreatic Cancer Action Network

FDA Approves Rasonque™ (daraxonrasib) Pancreatic Cancer Action Network